Cloning of suppressor gene of metastasis using subtraction hybridization method
Cloning of suppressor gene of metastasis using subtraction hybridization method
批准号:
05671026
负责人:
KUBOTA Tetsuro
金额:
$1.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1994
中文摘要
点击翻译按钮获取中文摘要
英文摘要
A gene (HFREP-1) that is overexpressed in hepatocellular carcinomas (HCCs) has been identified using a subtractive and differential cDNA cloning approach. We isolated the gene from a lambdagt10 cDNA library that was constructed from the poly(A)+-enriched RNA of a HCC specimen. The expression patterns observed in HCCs from 20 patients were classified into three types ; HFREP-1 was overexpressed in HCCs compared with non-tumorous regions (NTRs) in 55%, expressed weakly in both regions (15%) and strongly in both (30%). The largest cDNA insert contained 1231 base pairs coding 312 amino acids. The deduced protein sequence contained a hydrophobic leader peptide with a site for cleavage. The putative protein sequence showed strong homology with fibrinogen beta- and gamma- subunites and other fibrinogen-related proteins (FRPs), including four cysteine conserved residues. However, the HFREP-1 protein lacked a platelet-binding site, cross-linking region and thrombin-sensitive site, which are crucial for fibrin clot formation. The gene expression was studied in various organs in the rat and was specific to the liver, but little or none was detected in the fetal rat liver. Of the human carcinoma cell lines investigated, HFREP-1 was detected only in the HCC cell lines. We suggest that the HFREP-1 gene is a new member of the family of fibrinogens and has different features from other known FRPs and its expression is regulated oncodevelopmentally in hepatocytes.
期刊论文(40)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kubota,T,et al.: "Metastatic models of human cancer xenografts in the nude mouse: The importance of orthotopic transplautation" Journal of Cellular Biochemistry. 56. 4-8 (1994)
Kubota,T,et al.:“裸鼠中人类癌症异种移植物的转移模型:原位移植的重要性”细胞生物化学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kuo,T.et al.: "Site-specific chemosensitivity of human Small-cell long carcinoma orthotopically grown compared tosc in SCIP mice" Anticancer Research. 13. 627-630 (1993)
Kuo,T.et al.:“与 SCIP 小鼠中的 SC 相比,原位生长的人类小细胞长癌的位点特异性化学敏感性”抗癌研究。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kubota, T.: "Metastatic models of human cancer xenografted in the nude mouse : The importance of orthotopic transplantation." Journal of Cellular Biochemistry. 56 (1). 4-8 (1994)
Kubota, T.:“人类癌症异种移植到裸鼠的转移模型:原位移植的重要性。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Furukawa, T., Kubota, T., Watanabe, M., Kuo, T., Kase, S., Saikawa, Y., Tanino, H., Teramoto, T., Ishibiki, K., Kitajima, M.and Hoffman, R.M.: "Immunochemotherapy prevents human colon cancer metastasis after orthotopic onplantation of histologically-intac
古川 T.、久保田 T.、渡边 M.、郭 T.、加濑 S.、西川 Y.、谷野 H.、寺本 T.、石壁 K.、北岛 M. 和
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Furukawa,T.et al.: "A novel“patient-like"freatment model of human pancieattc cancer constructed using orthotopic transplartation" Cancer Research. 53. 3070-3072 (1993)
Furukawa, T. 等人:“使用原位移植构建的新型“患者样”人类胰腺癌模型”Cancer Research 53. 3070-3072 (1993)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 20 条
Novel chmosensitivity testing using molecular dynamics responding to anticancer drugs
-
批准号:17591435
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2005
-
负责人:KUBOTA Tetsuro
-
依托单位:
Chemo-resistance-related genes detected by cDNA microarray
-
批准号:14571225
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.56万
-
财政年份:2002
-
负责人:KUBOTA Tetsuro
-
依托单位:
New strategy in cancel therapy with reference tomethionine-depletion
-
批准号:07671329
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.6万
-
财政年份:1995
-
负责人:KUBOTA Tetsuro
-
依托单位:
Comparative study of concentrations of antitumor agents in serum and tumor in nude mouse and human
-
批准号:62570579
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.54万
-
财政年份:1987
-
负责人:KUBOTA Tetsuro
-
依托单位: